Filing Details

Accession Number:
0001209191-10-047489
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-09-24 21:22:15
Reporting Period:
2010-09-24
Filing Date:
2010-09-24
Accepted Time:
2010-09-24 21:22:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1316175 Anthera Pharmaceuticals Inc ANTH Pharmaceutical Preparations (2834) 201852016
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1281719 Debra Odink C/O Anthera Pharmaceuticals, Inc.
25801 Industrial Boulevard, Suite B
Hayward CA 94545
Vp, Pharmaceutical R&D No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-09-24 1,000 $4.20 26,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 95,928 Indirect By The Debra A. Odink Living Trust